| Literature DB >> 34042245 |
Theodore W Heyming1,2,3, Michelle A Fortier1,3,4,5, Sarah R Martin1,3,5, Bryan Lara1, Kellie Bacon1, Zeev N Kain1,3,5.
Abstract
BACKGROUND ANDEntities:
Keywords: COVID-19; behavioural; emergency medicine; paediatric; psychiatry/mental health
Mesh:
Year: 2021 PMID: 34042245 PMCID: PMC8242733 DOI: 10.1111/jpc.15579
Source DB: PubMed Journal: J Paediatr Child Health ISSN: 1034-4810 Impact factor: 1.929
Demographic and baseline characteristics of the study participants
| Children | ( |
|---|---|
| Age in years (M ± SD) | 7.04 ± 5.92 |
| Sex ( | 182 (50.0) |
| CASI‐R total score ( | 45.94 ± 16.42 |
| Cardiovascular symptoms | 13.69 ± 5.95 |
| Publicly observable signs | 13.67 ± 4.18 |
| Cognitive dyscontrol | 7.55 ± 3.95 |
| Respiratory symptoms | 11.38 ± 4.96 |
| PHBQ total score (M ± SD) | 74.41 ± 15.53 |
| General anxiety | 21.51 ± 5.29 |
| Separation anxiety | 13.96 ± 3.40 |
| Eating difficulties | 8.49 ± 2.01 |
| Aggression toward authority | 5.66 ± 1.24 |
| Apathy/withdrawal | 16.52 ± 3.62 |
| Sleep problems | 8.44 ± 2.10 |
| Parents | ( |
| Age in years ( | 34.78 ± 8.21 |
| Race/ethnicity ( | |
| Black | 4 (1.2) |
| Asian American/Pacific Islander | 32 (9.6) |
| Hispanic/Latino | 85 (25.4) |
| White | 202 (60.5) |
| Other | 10 (3.0) |
| Primary language ( | 272 (74.7) |
| ASI‐3 total score ( | 11.88 ± 13.66 |
| SF‐36 Health Survey ( | |
| Physical functioning | 84.62 ± 23.25 |
| Role‐physical | 67.10 ± 40.01 |
| Bodily pain | 85.29 ± 20.94 |
| General health | 67.98 ± 22.03 |
| Vitality | 54.87 ± 18.53 |
| Social functioning | 51.64 ± 24.27 |
| Role‐emotional | 68.02 ± 40.67 |
| Mental health | 72.43 ± 19.00 |
| COVID‐19 anxiety ( | 35.94 (10.35) |
ASI‐3, Anxiety Sensitivity Index; CASI‐R, Childhood Anxiety Sensitivity Index‐Revised; M, mean; PHBQ, Post‐Hospitalisation Behaviour Questionnaire; SD, standard deviation; SF‐36, MOS Short‐Form 36 Health Survey.
Fig. 1Frequency of new‐onset maladaptive behaviours exhibited by children (general anxiety (n = 107, 32.8%); separation anxiety (n = 82, 24.6%); issues with eating (n = 101, 30.4%); aggression toward authority (n = 88, 26.4%); apathy/withdrawal (n = 141, 43.0%); issues with sleep (n = 119, 35.9%)).
Predictors of new‐onset maladaptive behaviours on the PHBQ
| Lower quartile PHBQ score ( | Upper quartile PHBQ score ( |
| |
|---|---|---|---|
|
| |||
| Age in years ( | 6.77 ± 6.05 | 7.91 ± 5.85 | 0.132 |
| Race/ethnicity ( | 92 (64%) | 73 (69%) | 0.332 |
| Sex ( | 67 (47%) | 52 (49%) | 0.731 |
| Anxiety sensitivity (CASI‐R; | 43.09 ± 18.32 | 49.86 ± 14.56 | 0.044* |
|
| |||
| Mother's age in years ( | 34.61 ± 8.23 | 35.69 ± 7.75 | 0.511 |
| Father's age in years ( | 37.49 ± 8.73 | 38.23 ± 8.73 | 0.295 |
| Sex ( | 118 (83%) | 95 (90%) | 0.115 |
| State anxiety (VAS‐A; | 31.88 ± 28.57 | 52.72 ± 29.11 | <0.001* |
| Anxiety sensitivity (ASI‐3; | 9.48 ± 12.68 | 15.07 ± 14.51 | 0.002* |
| Physical function ( | 87.32 ± 21.89 | 79.63 ± 25.17 | 0.009* |
| Role limitations due to physical function ( | 71.38 ± 37.45 | 55.24 ± 42.98 | 0.002* |
| Role limitations due to emotional function ( | 73.11 ± 39.14 | 56.41 ± 42.84 | 0.001* |
| Energy/fatigue ( | 58.01 ± 16.81 | 49.51 ± 20.06 | <0.001* |
| Mental health ( | 78.46 ± 15.81 | 63.69 ± 21.05 | <0.001* |
| Social function ( | 53.58 ± 22.87 | 48.08 ± 26.97 | 0.795 |
| Pain ( | 86.62 ± 19.06 | 81.49 ± 23.63 | 0.057 |
| General health ( | 73.31 ± 18.64 | 61.33 ± 22.66 | 0.010* |
| COVID‐19 anxiety (M ± SD) | 33.81 ± 11.06 | 39.01 ± 9.10 | <0.001* |
*Statistically significant difference according to the independent samples t‐test. ASI‐3, Anxiety Sensitivity Index; CASI‐R, Childhood Anxiety Sensitivity Index‐Revised; M, mean; PHBQ, Post‐Hospitalisation Behaviour Questionnaire; SD, standard deviation; VAS‐A, Visual Analog Scale (0–100).
Results of logistic regression analysis for the association between scores on various subdomains of the PHBQ and new‐onset maladaptive behaviours during the implementation of stay‐at‐home guidelines for management of the COVID‐19 pandemic
| Variable |
| Odds ratio (CI) |
|
|---|---|---|---|
| Anxiety Sensitivity Index (ASI‐3) | 0.04 (0.01) | 1.00 (0.98–1.03) | 0.766 |
| Physical function | −0.01 (0.01) | 0.99 (0.98–1.01) | 0.224 |
| Role limitations due to physical function | 0.00 (0.01) | 1.00 (0.99–1.01) | 0.986 |
| Role limitations due to emotional function | −0.01 (0.01) | 1.00 (0.99–1.01) | 0.739 |
| Mental health | −0.04 (0.01) | 0.97 (0.95–0.98) | <0.001** |
| COVID‐19–anxiety | 0.42 (0.02) | 1.04 (1.01–1.08) | 0.006** |
**P < 0.01. ASI‐3, Anxiety Sensitivity Index; PHBQ, Post‐Hospitalisation Behaviour Questionnaire.